217 related articles for article (PubMed ID: 11586443)
1. The impact of repeated treatment with praziquantel of schistosomiasis in children under six years of age living in an endemic area for Schistosoma haematobium infection.
Mduluza T; Ndhlovu PD; Madziwa TM; Midzi N; Zinyama R; Turner CM; Chandiwana SK; Nyazema N; Hagan P
Mem Inst Oswaldo Cruz; 2001; 96 Suppl():157-64. PubMed ID: 11586443
[TBL] [Abstract][Full Text] [Related]
2. Benefits of annual chemotherapeutic control of schistosomiasis on the development of protective immunity.
Chisango TJ; Ndlovu B; Vengesai A; Nhidza AF; Sibanda EP; Zhou D; Mutapi F; Mduluza T
BMC Infect Dis; 2019 Mar; 19(1):219. PubMed ID: 30832614
[TBL] [Abstract][Full Text] [Related]
3. The effect of treatment on the age-antibody relationship in children infected with Schistosoma mansoni and Schistosoma haematobium.
Mutapi F; Mduluza T; Ndhlovu PD
Mem Inst Oswaldo Cruz; 2002; 97 Suppl 1():173-80. PubMed ID: 12426616
[TBL] [Abstract][Full Text] [Related]
4. Changes in specific anti-egg antibody levels following treatment with praziquantel for Schistosoma haematobium infection in children.
Mutapi F; Ndhlovu PD; Hagan P; Woolhouse ME
Parasite Immunol; 1998 Dec; 20(12):595-600. PubMed ID: 9990644
[TBL] [Abstract][Full Text] [Related]
5. Exposure, infection and immune responses to Schistosoma haematobium in young children.
Woolhouse ME; Mutapi F; Ndhlovu PD; Chandiwana SK; Hagan P
Parasitology; 2000 Jan; 120 ( Pt 1)():37-44. PubMed ID: 10726264
[TBL] [Abstract][Full Text] [Related]
6. Age-related antibody profiles in Schistosoma haematobium infections in a rural community in Zimbabwe.
Ndhlovu P; Cadman H; Vennervald BJ; Christensen NO; Chidimu M; Chandiwana SK
Parasite Immunol; 1996 Apr; 18(4):181-91. PubMed ID: 9223173
[TBL] [Abstract][Full Text] [Related]
7. Increased ShTAL1 IgE responses post-Praziquantel treatment may be associated with a reduced risk to re-infection in a Ghanaian S. haematobium-endemic community.
Asuming-Brempong EK; Ayi I; van der Puije W; Gyan BA; Larbi IA; Ashong Y; Frempong NA; Quartey JK; Otchere J; Jones FM; Wilson S; Dunne DW; Boakye DA
PLoS Negl Trop Dis; 2022 Mar; 16(3):e0010115. PubMed ID: 35263327
[TBL] [Abstract][Full Text] [Related]
8. Praziquantel treatment of school children from single and mixed infection foci of intestinal and urogenital schistosomiasis along the Senegal River Basin: monitoring treatment success and re-infection patterns.
Webster BL; Diaw OT; Seye MM; Faye DS; Stothard JR; Sousa-Figueiredo JC; Rollinson D
Acta Trop; 2013 Nov; 128(2):292-302. PubMed ID: 23022016
[TBL] [Abstract][Full Text] [Related]
9. Six rounds of annual praziquantel treatment during a national helminth control program significantly reduced schistosome infection and morbidity levels in a cohort of schoolchildren in Zimbabwe.
Mduluza T; Jones C; Osakunor DNM; Lim R; Kuebel JK; Phiri I; Manangazira P; Tagwireyi P; Mutapi F
PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008388. PubMed ID: 32569278
[TBL] [Abstract][Full Text] [Related]
10. Assessing the benefits of five years of different approaches to treatment of urogenital schistosomiasis: A SCORE project in Northern Mozambique.
Phillips AE; Gazzinelli-Guimaraes PH; Aurelio HO; Ferro J; Nala R; Clements M; King CH; Fenwick A; Fleming FM; Dhanani N
PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006061. PubMed ID: 29220347
[TBL] [Abstract][Full Text] [Related]
11. Schistosoma haematobium infection levels determine the effect of praziquantel treatment on anti-schistosome and anti-mite antibodies.
Rujeni N; Nausch N; Midzi N; Mduluza T; Taylor DW; Mutapi F
Parasite Immunol; 2012 Jun; 34(6):330-40. PubMed ID: 22429049
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and side effects of praziquantel treatment against Schistosoma haematobium infection among primary school children in Zimbabwe.
Midzi N; Sangweme D; Zinyowera S; Mapingure MP; Brouwer KC; Kumar N; Mutapi F; Woelk G; Mduluza T
Trans R Soc Trop Med Hyg; 2008 Aug; 102(8):759-66. PubMed ID: 18486169
[TBL] [Abstract][Full Text] [Related]
13. Predicted impact of mass drug administration on the development of protective immunity against Schistosoma haematobium.
Mitchell KM; Mutapi F; Mduluza T; Midzi N; Savill NJ; Woolhouse ME
PLoS Negl Trop Dis; 2014; 8(7):e3059. PubMed ID: 25079601
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of praziquantel and reinfection patterns in single and mixed infection foci for intestinal and urogenital schistosomiasis in Cameroon.
Tchuem Tchuenté LA; Momo SC; Stothard JR; Rollinson D
Acta Trop; 2013 Nov; 128(2):275-83. PubMed ID: 23791803
[TBL] [Abstract][Full Text] [Related]
15. A comparison of re-infection rates with Schistosoma haematobium following chemotherapy in areas with high and low levels of infection.
Mutapi F; Ndhlovu PD; Hagan P; Woolhouse ME
Parasite Immunol; 1999 May; 21(5):253-9. PubMed ID: 10320623
[TBL] [Abstract][Full Text] [Related]
16. Patterns of Schistosoma haematobium infection, impact of praziquantel treatment and re-infection after treatment in a cohort of schoolchildren from rural KwaZulu-Natal/South Africa.
Saathoff E; Olsen A; Magnussen P; Kvalsvig JD; Becker W; Appleton CC
BMC Infect Dis; 2004 Oct; 4():40. PubMed ID: 15471549
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of two closely spaced doses of praziquantel against Schistosoma haematobium and S. mansoni and re-infection patterns in school-aged children in Niger.
Garba A; Lamine MS; Barkiré N; Djibo A; Sofo B; Gouvras AN; Labbo R; Sebangou H; Webster JP; Fenwick A; Utzinger J
Acta Trop; 2013 Nov; 128(2):334-44. PubMed ID: 22940014
[TBL] [Abstract][Full Text] [Related]
18. Changes in the humoral immune responses after chemotherapy in single and co-infected individuals with Schisosoma haematobium and Plasmodium falciparum.
Zinyowera S; Muchaneta-Kubara CE; Mutapi F; Midzi N; Ndlovu PD; Mduluza T
Cent Afr J Med; 2006; 52(9-12):104-11. PubMed ID: 20353134
[TBL] [Abstract][Full Text] [Related]
19. Human IgE, IgG subclass, and IgM responses to worm and egg antigens in schistosomiasis haematobium: a 12-month study of reinfection in Cameroonian children.
Naus CW; van Dam GJ; Kremsner PG; Krijger FW; Deelder AM
Clin Infect Dis; 1998 May; 26(5):1142-7. PubMed ID: 9597243
[TBL] [Abstract][Full Text] [Related]
20. Population level changes in schistosome-specific antibody levels following chemotherapy.
Fukushige M; Mutapi F; Woolhouse MEJ
Parasite Immunol; 2019 Jan; 41(1):e12604. PubMed ID: 30467873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
